Richard Crowley, EVP Biopharmaceutical Operatio at SAVIENT PHARMACEUTICALS INC (SVNT), sold 9,200 shares at $2.35 ($22K) on 2012-05-01, disclosed to the SEC on 2012-05-01.
Scheduled sale ($22k) by EVP Biopharmaceutical Operatio under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2013-02-06 | $51K | — | Filing → |
| SVNT | SELL | 2013-02-04 | $2K | — | Filing → |
| SVNT | SELL | 2012-11-06 | $3K | — | Filing → |